Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Plasmodium falciparum mitochondrial electron transport chain (mETC) and redox system are essential for the parasite's survival and its transmission from humans to mosquitoes (Nixon et al., 2013). In the asexual blood stages, the mETC primarily functions to provide electrons for dihydroorotate dehydrogenase (DHODH), which is required for de novo pyrimidine biosynthesis (Sheokand et al., 2024). However, during the development of gametocytes—the sexual stages of the parasite—the mitochondria undergo a significant metabolic shift, becoming more active and relying on oxidative phosphorylation for ATP production (MacRae et al., 2013). This transition involves the upregulation of respiratory complexes and the development of mitochondrial cristae, making the system a vulnerable target for transmission-blocking interventions (Evers et al., 2021). Key components include the cytochrome bc1 complex (Complex III), NADH dehydrogenase 2 (NDH2), and various antioxidant enzymes that protect the parasite from oxidative damage (Müller et al., 2004). Drugs like atovaquone and experimental inhibitors like endochin-like quinolones (ELQs) target these pathways, exploiting structural differences between the parasite and human mitochondrial machinery to achieve selective toxicity (Nixon et al., 2013).
Inhibition of the cytochrome bc1 complex, inhibition of dihydroorotate dehydrogenase, inhibition of NADH dehydrogenase 2, disruption of mitochondrial membrane potential, and induction of oxidative stress.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Plasmodium falciparum mitochondrial electron transport chain and redox system (Pf-mETC/Redox).